This announcement is a separate document:
奥锐特药业股份有限公司关于2022年限制性股票激励计划第一个解除限售期解除限售条件成就暨上市流通的公告
Announcement of Orient Pharmaceutical Co., Ltd. on the 2022 Restricted Stock Incentive Plan, First Release Period, Release Restriction Conditions, Achievements in Releasing Sales Restrictions, and Listing Circulation
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.